Insider · CIK 0001780081
Adrian R. Krainer
Files at STOK (Stoke Therapeutics, Inc.). First filing Nov 18, 2025, latest Nov 26, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
STOK: Stoke Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | Stoke Therapeutics, Inc. | $1.2M 40,472 shares | -11% | +414% from low-15% from high | |
| 33Weak | Stoke Therapeutics, Inc. | $1.1M 40,472 shares | -10% | +349% from low-26% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 24, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -40,472 | $29.72 | $1.2M | 323,774 | Nov 26, 2025 |
| Nov 14, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -19,790 | $26.61 | $527k | 384,928 | Nov 18, 2025 |
| Nov 14, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -20,682 | $27.34 | $565k | 364,246 | Nov 18, 2025 |
| Jun 3, 2025 | STOK Stoke Therapeutics, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +29,747 | $0.00 | $0 | 29,747 | Jun 4, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.